Open Access311.3: A 5-Year Prospective, Randomized, Open-Label Study of Standard Versus Low-Dose Prolonged-Release Tacrolimus With Or Without ACEi/ARB in Kidney Transplantation
Author(s) -
Sandra M. Cockfield,
Patricia Campbell,
Marcelo Cantarovich,
Azim S. Gangji,
Ahmed Shoker,
Anthony M. Jevnikar,
FelixMauricio MonroyCuadros,
Peter Nickerson,
MarieEve Paquet,
G. V. Ramesh Prasad,
Lynne Senécal,
Jason J. Schwartz,
JeanLuc Wolff,
David Rush
Publication year - 2022
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/01.tp.0000886376.35615.a8
Subject(s) - medicine , basiliximab , urology , tacrolimus , prednisone , transplantation , mycophenolic acid , kidney transplantation , trough level , proteinuria , randomized controlled trial , gastroenterology , renal function , kidney